Skip to Main Content
Back to News

Lobbying Update: $30,000 of BAXTER INTERNATIONAL lobbying was just disclosed

None

$30,000 of BAXTER INTERNATIONAL lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Reimbursement, coding and coverage for inpatient and outpatient products. Reimbursement, coding and coverage for inpatient and outpatient products."

You can find more data on corporate lobbying on Quiver Quantitative.

AXTI Hedge Fund Activity

We have seen 17 institutional investors add shares of AXTI stock to their portfolio, and 38 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXTI Analyst Ratings

Wall Street analysts have issued reports on $AXTI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B. Riley Securities issued a "Buy" rating on 07/10/2025
  • Wedbush issued a "Outperform" rating on 05/02/2025

To track analyst ratings and price targets for AXTI, check out Quiver Quantitative's $AXTI forecast page.

AXTI Price Targets

Multiple analysts have issued price targets for $AXTI recently. We have seen 2 analysts offer price targets for $AXTI in the last 6 months, with a median target of $4.2.

Here are some recent targets:

  • Matt Bryson from Wedbush set a target price of $4.1 on 08/01/2025
  • Dave Kang from B. Riley Securities set a target price of $4.3 on 07/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles